Invited Speakers


Dr Elaine Abrams 
Professor of epidemiology and pediatrics at Columbia University and the senior director for research at ICAP.

Elaine Abrams, MD, is a professor of epidemiology and pediatrics at Columbia University and the senior director for research at ICAP.  At ICAP Dr Abrams leads a large and varied research portfolio that addresses critical scientific questions in HIV prevention, care and treatment. She is also responsible for the development and implementation of pediatric and perinatal prevention initiatives within ICAP supported programs in Sub Saharan Africa.  Dr Abrams has been an active investigator in the field of maternal-infant HIV transmission and the natural history of HIV disease in infants, children and youth since the recognition of the epidemic in the United States. She developed a comprehensive research and care program for woman and children with HIV infection in Central Harlem, the Family Care Center; has been actively involved in the development of international, national and local guidelines and policies for care and treatment; has conducted multiple studies, clinical trials and implementation science studies in the area of maternal and child HIV. She is currently the chair of the HIV treatment scientific committee of the NIH funded IMPAACT clinical trials and co-chair of the clinical guidelines group for World Health Organization 2015 HIV guidelines. 

elaine abrahams

Dr Paul Drain  

Paul Drain, MD, MPH, is Assistant Professor in the Departments of Global Health and Medicine (Infectious Diseases). His research focuses on diagnostic point-of-care tests and clinic-based screening for Tuberculosis and HIV in resource-limited settings. He completed his infectious disease training at Massachusetts General Hospital and Brigham and Women's Hospital in Boston. He received a Faculty Teaching Award from Harvard Medical School, where he co-teaches "Introduction to Social Medicine and Global Health" to first-year medical students. His research has been supported by the National Institutes of Health, Harvard Global Health Institute, Harvard University, Infectious Disease Society of America, and AIDS Healthcare Foundation.

paul drain

Prof Joseph (Joe) Eron  
Joseph J. Eron Jr. MD is a Professor of Medicine and Epidemiology in the Division of Infectious Diseases at the University of North Carolina at Chapel Hill. He received his Infectious Diseases and HIV training axt Massachusetts General Hospital under Drs. Martin Hirsch and Richard D'Aquila. He is the Principal Investigator of the HIV/AIDS Clinical Research Unit at UNC-CH and the Director of the Clinical Core for the UNC Center for AIDS Research (CFAR). In addition he leads the UNC Acute HIV Infection research team and is a collaborator in the UNC HIV Cure initiative. Over the last eight years Dr. Eron has led the development of the UNC HIV CFAR Clinic Cohort which includes over 3500 HIV infected individuals and has active collaboration and membership in the NA ACCORD and CNICS cohorts. Dr. Eron has over 300 publications in peer reviewed journals focusing predominantly on antiretroviral therapy, resistance, pharmacology and transmission. Recent work has included publications from the UNC HIV Clinical Cohort, the AIDS clinical trials Group, HPTN 052 and IAS-USA HIV treatment guidelines in JAMA 2014. Dr. Eron has worked extensively in the area of HIV drug development and led or participated in original studies of many antiretroviral therapies. He also continues as an active HIV and Infectious Disease clinician. He was awarded the HIVMA HIV Clinical Educator Award in 2013. joe eron


Dr Andrew Kambugu  
M.Med, FRCP (London)  

Dr. Kambugu is the Director of the Research Program at the Infectious Diseases Institute (IDI) at the Makerere University College of Health Sciences (MakCHS), and is an honorary Senior Lecturer in the Department of Medicine at MakCHS. He is also an adjunct Associate Professor at the University of Minnesota (UMN), USA. He received his basic medical training as well as his residency in Internal Medicine at Makerere University in Uganda and undertook specialist training in Infectious Diseases in the USA and Canada. He has over 12 years of clinical experience in HIV medicine and is a member of 2 National HIV Subcommittees (Adult Antiretroviral Therapy and HIV Drug Resistance) of the Ugandan Ministry of Health. He directed the HIV Clinic at the IDI for seven years. He is a Fellow of the Royal College of Physicians (FRCP), London, UK.

Dr. Kambugu' s research interests include HIV treatment outcomes in resource limited settings, as well as the diagnosis and management of opportunistic infections in these settings with a focus on cryptococcal meningitis and tuberculosis. He has accrued considerable experience in assembling clinical cohorts as well as conducting fairly large clinical trials in Uganda. He is a principal investigator on a number of clinical trials spanning the fields of HIV therapeutics, HIV treatment strategies and implementation science in Uganda.

andrew kambugu

Key Speakers

Dr Sandile Buthelezi  

Sandile Buthelezi is a seasoned medical practitioner with more than 15 years' experience in health governance and policy environment in both the public and the non-profit sector environment. After serving as a Clinician as well as the Medical Superintendent in a number of hospitals in KwaZulu-Natal, Sandile served as the KwaZulu-Natal Provincial Head of the HIV, TB and Maternal and Child Health programs for 10 years, during which tenure he led the implementation of the KZN Antiretroviral program which todate has registered more than 1 million patients ever initiated on ART since 2004.

In 2010, Sandile joined ICAP at Columbia University as the Director of Programs for the Multi-Country Columbia AIDS program in South Africa. This was a followed by a stint as the Senior Technical Lead for the DFID funded SARRAH programme managed by HLSP, a division of the Mott MacDonald group. In this portfolio, he provided technical oversight to the work that was aimed at supporting the health reforms in South Africa. In 2014, Sandile was re-appointed by ICAP at Columbia University as the Country Director for South Africa. In this portfolio, Sandile provides strategic leadership to the ICAP's diverse portfolio in the country which includes research, academic work as well as technical support to the ministry of health. In addition, the ICAP South Africa office, under Sandile's leadership, provides support to select programs implemented by ICAP in the Africa region.

sandile buthelezi

Dr Francesca Conradie  

Dr Francesca Conradie is a joint appointee of Right to Care and the Clinical HIV Research Unit (CHRU). She is appointed as Right to Care's Clinical Advisor to Sizwe Hospital, a hospital for the treatment of multidrug resistant TB. She is charged with the integration of HIV and TB services at this site.

Francesca obtained her MBBCh from Wits University in 1988. She was involved in general practice until she joined CHRU in 2000. Since then she has obtained a Diploma in HIV Management; a Diploma of Tropical Medicine and Hygiene; and a Higher Diploma in Epidemiology (from the University of London). She is currently studying for her MSc in Epidemiology from the London School of Tropical Medicine and Hygiene.

Dr Conradie joined CHRU as a sub-investigator. She has since been the principal investigator on a number of trials. She worked in the HIV clinic at Helen Joseph Hospital from 2001 until 2005. In that time, she participated in the start of the ARV rollout. She has gained extensive experience in ARV therapy and its complications, and in opportunistic infections.

She assisted with the writing CIPRA protocol and was involved in the implementation of this project at the Perinatal HIV Research Unit (PHRU). In 2005, she was appointed Project Leader of CIPRA Project 1. She also led other ACTG trials (5208 and 5207). She is the site leader for HPTN 052. In 2005, Francesca was promoted to Deputy Director of CHRU.
Francesca frequently lectures for Right to Care, the Foundation for Professional Development, and other institutions. She has authored and co-authored many journal articles and abstracts. She assisted with the writing of the Southern African HIV Clinicians' Society guidelines for antiretroviral therapy in adults in 2008, and is leading the Society's development of guidelines for antiretroviral drug resistance testing.

Francesca is a member of the Human Research and Ethics Committee of Wits University.

franchesca conradie

Prof Glenda Gray  
MBBCH; FCP (Paed) SA, DSc (honoris causa) and a NRF A rated scientist 

Glenda Gray is President of the Medical Research Council. She is a Professor of Paediatrics in the Faculty of Health Sciences, at the University of the Witwatersrand. She is also a Professor in the Vaccine and Infectious Disease Division, at the Fred Hutchinson Cancer Research Institute. She was the Executive Director of the Perinatal HIV Research Unit before joining the MRC to lead their Office of AIDS Research. She is the Co-PI of the NIH funded HIV Vaccine Trials Network and the Director of HVTN International Programs. In 2002, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of Mother-to-Child Transmission of HIV-1. She is a member of the Academy of Science in South Africa, and chairs their standing committee on health. She is a member of the Institute of Medicine, of the National Academies, serves on their Global Health Board.

Gray has also been awarded the IAPAC "Hero of Medicine" award for work done in the field of HIV treatment in children and adults. In 2009, James McIntyre and Gray received the N'Galy-Mann lectureship in recognition of their HIV research contribution in South Africa. In June 2012 she received a DSc honoris causa from the Simon Fraser University, Vancouver. She has also been admitted into the American Academy of Microbiology in 2012. In 2013 she received the EDCTP's outstanding Africa Scientist Award as well as South Africa's highest honour, the Order of Mapungubwe, granted by the president of SA for achievements in the international area which have served South Africa's interest.


Prof Gary Maartens  
Professor Maartens is head of the Division of Clinical Pharmacology at the University of Cape Town, South Africa and a chief specialist physician (internist) at Groote Schuur Hospital, where he does clinical service in internal medicine and infectious diseases. His main clinical research interests are HIV-associated tuberculosis, drug-resistant tuberculosis, and antiretroviral therapy in resource-limited settings. He has published over 150 peer reviewed articles, including invited seminars on both tuberculosis and HIV for Lancet.

He has been involved in guideline development for the management of HIV and tuberculosis for the World Health Organization and the Centers for Disease Control and Prevention. He serves on the Tuberculosis Transformative Science Group of the AIDS Clinical Trials Group, NIAID.

profgary maartens

Prof Greame Meintjes  

Graeme Meintjes is an Associate Professor of Medicine, an Infectious Diseases Physician and a clinician scientist based at the University of Cape Town. He obtained his medical degree and PhD from UCT, and a Masters in Public Health from Johns Hopkins University. He is a fellow of the College of Physicians of South Africa, and the Royal College of Physicians of Glasgow, and member of the Academy of Science of South Africa.

He has been awarded two Wellcome Trust fellowships, and holds the DST/NRF SARChI Chair of Lung Infection and Immunity in Poverty-related Diseases at UCT. His research focuses on improving understanding of pathogenesis, diagnosis and treatment of the clinical complications that affect patients with advanced HIV disease, including HIV-associated tuberculosis, immune reconstitution inflammatory syndrome and cryptococcal meningitis.

profgraeme meintjies

Prof Marc Mendelson  

Professor Marc Mendelson studied Medicine at St Mary's Hospital, London. He specialized in Infectious Diseases at Addenbrookes Hospital, Cambridge, where he attained his PhD before moving to The Rockefeller University, New York, to work on tuberculosis and innate immunity. Marc moved to University of Cape Town (UCT) in 2001 to continue his research and in 2007, was appointed as Principal Specialist and Head of Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital, UCT.

Marc is the current President of the Federation of Infectious Diseases Societies of Southern Africa. His main focus is on antimicrobial resistance (AMR). He is co-chair of the South African Antibiotic Stewardship Programme (SAASP), co-author of the South African AMR Strategy Framework and is the South African lead for AMR on the Global Health Security Agenda. He has worked with national government and WHO to support the development of the Global Action Plan for antimicrobial resistance.

profmarc mendelson

Professor Thumbi Ndung'u  
Investigator, KwaZulu-Natal Research Institute for TB and HIV (K-RITH); Professor and Victor Daitz Chair in HIV/TB Research, University of KwaZulu-Natal  

Thumbi Ndung'u is an Investigator and Max Planck Group Leader at the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH). He is a Professor and Victor Daitz Chair in HIV/TB Research and Director of the HIV Pathogenesis Programme (HPP) at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal. He holds the South African Research Chair in Systems Biology of HIV/AIDS. He is also a Howard Hughes Medical Institute International Early Career Scientist. He graduated with a Bachelor of Veterinary Medicine degree from the University of Nairobi, Kenya, and obtained a PhD in Biological Sciences in Public Health from Harvard University, United States. His research interests are host-pathogen interactions, especially antiviral immune responses. He is leading a multidisciplinary team of researchers working in the fields of HIV and TB pathogenesis and vaccine development. He has special interest in capacity building for biomedical research in Africa.

profthumbi ndungu

Prof Catherine Orrell  
MBChB MSc MMed (Clin Pharmacol) | Assoc. Prof at the Desmond Tutu HIV Centre / Foundation  
Dr Orrell is a clinical pharmacologist and HIV physician who has been working with HIV-infected patients in clinical trials and observational cohorts since 1997. She has led the successful Desmond Tutu HIV Centre Treatment Division and Clinical Trials Unit for the last 14 years. Dr Orrell has been the principal and co-investigator on more than 25 clinical trials of antiretroviral drugs, including a range of efficacy, toxicity and dosing studies, both pharmaceutical and investigator-driven. She has in-depth experience of conducting research in both state-of-the-art research facilities at the University of Cape Town as well as in primary health care clinic environments, including playing a central role as site investigator in the design and implementation of the CIPRA-SA trial of nurse-versus doctor-driven community ART services, which has reformed delivery of ART services in South Africa. Her particular interests are in HIV pharmacology, adherence/retention in care and resistance to ART and she has an extensive publication record in these fields. Dr Orrell's adherence work has contributed to policy in the Western Cape and nationally, as well as to international guidelines. prof catherine orell

Prof Helen Rees  

Professor Helen Rees is Executive Director of the Wits Reproductive Health and HIV Institute of the University of Witwatersrand where she is a personal Professor in the Department of Obstetrics and Gynaecology. She is the chair of the South African Medicines Control Council. She is an Honorary Professor at the London School of Hygiene and Tropical Medicine, an honorary Fellow of Cambridge University’s Murray Edwards College and an alumnus of Harvard Business School.  Prof Rees has received many awards for her work in HIV, reproductive health and vaccines. In 2001 she was made an Officer of the British Empire by Queen Elizabeth for her contribution to global health. In 2015she received two prestigious science awards; the Oppenheimer award for Science and the National Science and Technology Foundation’s Lifetime Achievement award for science.   Prof Rees has served on many global scientific committees and currently chairs the WHO’s African Advisory Group on Immunisation, the WHO’s International Health Regulation Emergency Committee on Polio,  the WHO’s committee on Ebola vaccines and the WHO’s Expert Committee on maternal immunization.

 Helen ReesEdited

Dr Theresa Rousouw  

Prof Theresa Rossouw, qualified as a medical doctor (MBChB) and completed an MPhil (Applied Ethics), MPH (Epidemiology and Biostatistics) and a PhD. She is a HIV clinician and was the Clinical Head of the Antiretroviral Clinic at Tshwane District Hospital from 2005 until 2010. She started a referral clinic for patients with HIV-associated drug resistance in 2010 and has since been working as HIV specialist mentor in the Tshwane / Metsweding district with the aim of improving HIV care and treatment at the primary care level. Her research focus has been on the mechanisms of development and consequences of HIV-1 drug resistance and HIV-associated chronic immune activation.

She is a consultant at the Department of Family Medicine and a Researcher at the Department of Immunology at the University of Pretoria. Her HIV work, specifically her HIV-associated resistance work, has culminated in membership of the Southern African Treatment and Resistance Network (SATuRN), the Southern African HIV Clinicians Society's (SAHIVCS) Guideline Committee, TUKS AIDS Reference group, the SAHIVCS Northern Gauteng HIV Resistance Group, and an international working group on the Social and Ethical Consequences of HIV Cure Research. She also serves on two institutional research ethics committees and a Data Safety Monitoring Board. She has published 31 articles in peer-reviewed journals and is a frequent reviewer of theses, protocols and manuscripts.

missing female

Dr Francois Venter  
MD, FCP (SA), Mmed, DTM&H, Dip HIV Management (SA)  

Dr Venter is the Deputy Executi ve Director of the Wits Reproductive Health and HIV Institute at the University of the Witwatersrand. He leads multiple antiretroviral treatment optimisation studies, and has an active interest in public sector access to HIV services. He is currently working on new first and second line antiretroviral options, patient linkage to care interventions, and self-testing projects. Previously, he lead large PEPFAR-funded HIV programmes in South Africa, including one that focused on truckers and sex workers. He has been represented on South African and regional guidelines for over a decade, having done almost all his training within South Africa.

His major research currently focus on low dose stavudine, low dose darunavir in second line treatment, and combinations of newer drugs to improve the resistance and potency of first line, as well as using patient information to drive improved linkage to care after diagnosis.

Francois VenterEdited

Dr Brian Williams  
Epidemiologist, WRHI, University of the Witwatersrand,Johannesburg South Africa.  

Brian Williams is from South Africa. He obtained his Ph.D. in physics in 1971 at Cambridge University in England. After several years of research in solid state physics he moved into ecology in 1987 and worked on methods to control tsetse flies and trypanosomiasis in Tanzania and Kenya, and subsequently at Oxford University and the London School of Hygiene and Tropical Medicine. He returned to South Africa in 1994 to work on the epidemiology of occupational diseases of mine workers, mainly silicosis and tuberculosis. He ran a major project to control HIV and AIDS in Carletonville, the biggest gold mining complex in the world, focussing on mine workers, sex workers and adolescents. He set up SACEMA, the South African Centre for Epidemiological Modelling and Analysis, based in Stellenbosch, South Africa, whose aim is to develop analytical capacity in public health in Africa with a view to managing some of the many diseases that continue to ravage the continent. In 2001 he took up a position at the World Health Organization (WHO) in Geneva working on TB and HIV. He was the senior author on two key modelling papers that demonstrated the impact that anti-retroviral therapy could have on the epidemic of HIV and on the epidemic of HIV-related TB in Africa. He is one of the founders of TTEA, Test-and-Treat to End AIDS, which is dedicated to promoting the use of anti-retroviral therapy to end the epidemic of HIV. After retiring from WHO he returned to South Africa where he continues to do consulting work for WHO, UNAIDS and SACEMA and works part-time for the Wits Reproductive Health and HIV Institute (WRHI).

Brian Williams 


Dr  Musaed Abrahams  
Dr Musaed Abrahams has spent the last 12 years in the public and NGO sectors working in HIV/AIDS care in SA, Zimbabwe, Malawi and Mozambique. He has a special interest in developing e-health tools and resources for clinicians. In 2013 he founded Avirohealth, a company with a focus on health systems strengthening, through the application of technology and design. Projects include e-learning courses for the SA HIV Clinicians Society and the Aviro HIV Clinical Mentor, a decision-support application for clinicians which is supported by MTN Foundation. drmusaeed abrahams 

Mr Siraaj Adams  
Mr Adams is the General Manager for HIV at Metropolitan Health Group, based in Cape Town, with over 10 years of experience in disease management. He is a national board member of the South African Business Coalition for Health and AIDS(SABCOHA) as well as TB/HIV care. In his current role, he oversees the HIV YourLife Program, which provides HIV disease management services—including antiretroviral medication, blood tests, TB management, and other services—for over 150,000 members. He also helps manage Metropolitan's partnership with CHAPS to provide voluntary medical male circumcision services as an HIV preventive benefit. Adams holds a Bachelor of Pharmacy degree as well as Masters in Business Administration and has submitted his thesis for review to complete his Masters in Public Health degree siraj adams

Dr Mo Archary  

Dr Archary is a Paediatric Infectious Disease Specialist in the Department of Paediatrics and Child Health at King Edward VIII Hospital affiliated to the Nelson R Mandela School of Medicine, University of KwaZulu-Natal. He is actively involved with the management of children with HIV both locally and nationally within South Africa and is the Co-Chair of South African National AIDs Council (SANAC) Treatment and Care technical task team and the Paediatric ARV Treatment Guideline committee. His research interests include antiretroviral drug therapeutics, viral resistance and optimal timing of initiation of antiretroviral therapy in the developing world.

 Moherndran ArcharyEdited

Prof Linda-Gail Bekker  
Linda-Gail Bekker, is Deputy Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, UCT and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is a physician scientist with a keen interest in HIV, Tuberculosis and related diseases. Her doctoral work focused on the host response to Tuberculosis both with and in the absence of HIV co-infection. Subsequently her research interests have expanded to include programmatic and action research around antiretroviral roll out and TB integration, prevention of HIV in a women, youth and men who have sex with men. She has contributed to a number of publications emanating from the Desmond Tutu HIV Centre on topics relevant to the South African HIV and TB epidemics. In her role in the Foundation, she is passionate about community development. In 2016, she will assume her role as President of the International AIDS Society for two years  Linda GailEdited

Dr Carol-Ann Benn  


Prof Carol-Ann Benn is a Fellow of the College of Surgeons of South Africa with a special interest in Breast Disease. Her capacity as Head of the Breast Unit of Helen Joseph Hospital proves her long career and her commitment to clinical excellence in this field of Medical speciality. Prof Benn offers service to society and the greater medical community, both local and international, through her contributions, published and presented, and she is recognised internationally as a leader in Breast Disease. As lecturer in the Department of Surgery at the University of the Witwatersrand, she contributes towards the education of healthcare professionals.

Through the organisation of foreign and private funding, Prof Benn was able to establish the breast Health Foundation, various Breast Health Care forums and outreach programmes and in representation on numerous Medical Boards and Health Care Committees, Prof Benn has paved the way for the improvement of women’s health care; has contributed towards the uplifting of women in society and has opened channels for public awareness of breast health
 Carol AnnBenneDITED

Dr Vivian Black  
BSc; MBBCh; DTMH; MSc Infectious Diseases  

Vivian Black is a medical doctor with her master’s in infectious diseases. She has extensive experience in the field of HIV, particularly with regards women’s health including PMTCT, safer conception, violence and sexually transmitted infections. She is well published and provides technical support to the NDoH on PMTCT and STIs.
She is currently the technical specialist of implementation sciences, Wits Reproductive Health and HIV Institute. Dr Black previously ran the maternal health and HIV programmes within the inner city of Johannesburg for over ten years. She developed and implemented interventions to improve HIV related pregnancy outcomes within antenatal clinics in the inner-city. Vivian has served on data safety monitoring boards for three vaccine studies conducted in pregnant women.

The combination of clinical and laboratory based microbiological experience, experience working with pregnant women and her research experience places Dr Black in an excellent position to contribute to vaccine related work among pregnant women.
 Vivian BlackEdited1

Dr Andrew Black  

Andrew Black is a pulmonologist currently employed at Wits RHI where he is Technical Head of the Adult HIV and TB team. He has clinical experience in the public sector where he spent many years working as a physician and pulmonologist. His interests are TB and OI’s in HIV and is currently involved with a Health systems grant to strengthen HIV and TB care in the public sector.

 Andrew BlackEdited

Dr Sergio Carmona  
BSc Hons, MBBCh, FPath (SA)  

Dr Sergio Carmona received his basic science degree and Medical degree from the University of the Witwatersrand in Johannesburg. He completed his fellowship in haematology at the Baragwanath Chris Hani Hospital in Soweto and the Charlotte Maxeke Academic Hospital in Johannesburg, South Africa. He is the pathologist in-charge of one of the largest routine HIV virology laboratories in the region, providing Early Infant Diagnosis, HIV drug resistance testing among other relevant assays. He was the former pathologist at Executive Committee of the National Health Laboratory Service from 2012- 2015, an over 7000 employee organisation with 268 laboratories that provides diagnostic pathology to 80% of South Africans.

In 2010 Dr Carmona was seconded to the national priority programme to expand viral load testing in South Africa, which has successfully reached close to 2.8 million tests per annum.
He is interested in the areas of early infant diagnosis, HIV viral load monitoring, evaluation of POCT, HIV drug resistance and HIV related Monitoring and Evaluation studies. He is also member of the WHO HIV drug resistance working group and the WHO 2015 HIV clinical guidelines development group.

 Sergio CarmonaEdited

Prof Ashraf Coovadia  

Professor MBChB, DCH (CMSA), Dip HIV Man (CMSA) FCP (Paed CMSA)


Ashraf is the Head of Department, Dept of Paediatrics and Child Health, University of the Witwatersrand (Rahima Moosa Mother and Child Hospital, Johannesburg). He completed his undergraduate training at the University of Zambia in 1990 and his paediatric postgraduate training at the University of the Witwatersrand in 1998. Since 1998 Ashraf has championed the cause of Paediatric HIV/AIDS and Prevention of Mother to Child Transmission of HIV (PMTCT). Prof Coovadia is the Children Sector representative on SANAC (South African National AIDS Council) and is an expert on national Paediatric Antiretroviral Treatment Guidelines and Prevention of Mother to Child Transmission (of HIV) guidelines committees. He is actively involved with research projects involving women and children who are HIV-infected. Prof Coovadia was a previous executive member of the Resuscitation Council of Southern Africa and past representative on the Paediatric Task Force of the International Liaison Committee on Resuscitation (ILCOR) 2001 -2010.His current area of interest includes  clinical trials involving HIV-infected pregnant women and children, with a view to optimising the PMTCT programme and paediatric treatment regimens.

 Ashraf HassenEdited

Prof Mark Cotton  
Professor Cotton is Head of Division of Paediatric Infectious Diseases and Director of the Children’s Infectious Diseases Clinical Research Unit (KID-CRU) at Tygerberg Children’s Hospital (TCH), Faculty of Health Sciences, Stellenbosch University. He completed a 3 year fellowship in paediatric infectious diseases at University of Colorado- Denver, and also conducted laboratory-based research on apoptosis in paediatric HIV under the supervision of Dr Terri Finkel at the National Jewish Centre for Respiratory Diseases and Immunology.

On return to Tygerberg Academic Hospital, he completed a PhD on the role of apoptosis in paediatric HIV infection. He has been conducting a number of multicentre trials focusing on TB and HIV in children.

He has been a member of WHO technical task teams on HIV staging, ART and guidelines for Tuberculosis in children since 2004. He is a Specialist in Pediatric Infectious Diseases with extensive experience in managing HIV-infected children. Professor Cotton has been co-PI and investigator in a number of randomized clinical trials in children, both studies ART strategy and isoniazid prophylaxis and also ARV pharmacokinetics in HIV-infected children. The majority of studies are funded through the International Maternal Pediatric Adolescent AIDS Clinical Trial Group (IMPAACT). He is also the director of the Children’s Infectious Diseases Clinical Research Unit (KID-CTU) (clinical trial unit).

Prof Mark Cotton

Dr Joel Dave  



Joel is an endocrinologist in Private Practice in Cape Town.  He is also a part-time senior lecturer in the Division of Endocrinology and Diabetic Medicine, UCT and Groote Schuur Hospital where he is involved in research projects with Prof Levitt. Their main research focus is ‘The metabolic complications of anti-retroviral therapy’

 Joel DaveeDITED

Ms Robyn Eackle  



Robyn Eakle is a Senior Research at Wits Reproductive Health and HIV Institute in South Africa, and a Research Fellow at the London School of Hygiene and Tropical Medicine. Robyn has a Masters in Public Health from the University of Southern California, and a diverse background in business, philanthropy, and public health, having previously worked for corporations and law firms in the US as well as the Bill and Melinda Gates Foundation. She has been focused on the development and delivery of new HIV prevention technologies for the past seven years, in particular pre-exposure prophylaxis (PrEP) for HIV prevention. She is currently leading a demonstration project offering PrEP and Immediate Treatment to female sex workers in South Africa. Robyn’s research interests lie in the implementation of new prevention technologies, and the factors influencing successful implementation.

 missing female

Prof Brian Eley  

Head of Pediatric Infectious Diseases Unit , Red Cross War Memorial Children’s Hospital Associate Professor, School of Child and Adolescent Health, University of Cape Town


Brian Eley is head of the Paediatric Infectious Diseases Unit at Red Cross War Memorial Children’s Hospital He is an associate professor in the Department of Paediatrics and Child Health, University of Cape Town. His research interests include the outcome of children treated with antiretroviral therapy, the diagnosis of childhood TB, and bloodstream infection. He is the current chair of the Child and Adolescent Committee of the Southern African HIV Clinicians Society.

 Brian EleyeDITED

Dr Ute Feucht  
M.B.,Ch.B. ; FCPaed (SA); MMed Paediatrics; Diploma in HIV Management (SA); CAHM
Ute Feucht did her initial undergraduate medical training at the University of Stellenbosch and her postgraduate Paediatric training at the University of Pretoria.  She was then appointed as a Specialist Paediatrician at Kalafong Hospital and the University of Pretoria on a joint appointment.  As the clinical manager of the Paediatric HIV services at the hospital her primary clinical responsibility was to establish and supervise the rapidly expanding Paediatric antiretroviral therapy (ART) clinic. Additional work duties included under- and post-graduate student training and research.  In September 2012 she was appointed as the Paediatrician in the newly established Tshwane District Clinical Specialist Team, tasked with improving Child Health services, including HIV-services, in the Tshwane District.  She is enrolled for her PhD in Paediatrics at the University of Stellenbosch, researching various aspects of the implementation of the Paediatric HIV programme.  Additional interests include HIV-exposed-but-uninfected children, childhood growth and tuberculosis  Ute FeuchtEdited

Dr Cindy Firnhaber  
Cynthia S. Firnhaber is a US-trained internal medicine physician dedicated to the care of HIV patients. She has been involved in the care of HIV patients intermittently in Southern Africa since 1990 and has dedicated her professional life to the clinical care of these patients. Dr. Firnhaber has participated and led clinical studies testing better treatment and care strategies for HIV-positive patients. In addition to training doctors in the USA and Johannesburg, her research focus has been on the care of co-morbidities in HIV-infected patients with strong interests in hepatitis B and Human Papillomavirus. The lack of cervical cancer screening led to her development and implementation of several cervical cancer-screening programs. Dr. Firnhaber oversees the largest HPV prevention and treatment clinic for HIV patients in the region - based at the University of the Witwatersrand in Johannesburg, South Africa  Cindy FirnhaberEdited

Dr Louise Gilbert  
Louise Gilbert completed her undergraduate studies at the University of the Witwatersrand graduating with a Bachelor of Medicine and Bachelor of Surgery (MBBCh) degree in 2004. After completing her ‘Zuma’ years and a year of MO time at Coronation Hospital (now Rahima Moosa Mother and Child Hospital), Louise joined RHRU (now Wits RHI) as a junior doctor in their ‘Fast Track’ Clinicians HIV training programme. Louise went on to complete a Diploma in HIV Management, Higher Diploma in Sexual Health and HIV Medicine and a Masters in Public Health degree, the latter specialising in the field of Maternal and Child Health. Louise is currently employed by Right to Care as the Gauteng Provincial Programme Manager of their Health Systems Strengthening programme in that province. Louise is passionate about the South African public health system and ensuring the provision of comprehensive high-quality healthcare for all South Africans. Dr Louise Gilbert

Dr  Bernadett Gosnell  
MBChB; Masters in Chemistry; MD  
Dr Bernadett Gosnell is a medical officer in Infectious Diseases at King Edward VIII hospital, Durban. Her main areas of work are tertiary level care of sexually transmitted diseases, HIV drug resistance and advanced retroviral disease. Her interest lies in oncology and she hopes to expand her career into that area. She gained her knowledge through working in different disciplines at a number hospitals in KZN and her passion for helping patients to help themselves sustains her enthusiasm.  Bernadett GosnellEdited

Dr Nelesh Govender  
Dr Nelesh Govender is a pathologist (microbiology/ mycology) at the National Institute for Communicable Diseases (NICD) in Johannesburg and associate professor in the Division of Medical Microbiology at the University of Cape Town. Dr Govender runs the COTHI-Mycology Reference Laboratory at NICD. His work is focused on public health surveillance and outbreak responses to invasive fungal diseases. His group currently conducts surveillance for cryptococcal meningitis, candidaemia, dimorphic fungal infections and aspergillosis. Recently, Dr Govender has been involved in efforts to implement and monitor a screen-and-treat intervention for cryptococcal disease in collaboration with the South African Department of Health and other partners. As a member of several Guidelines Committees, he is also involved in writing national and international guidelines for fungal diseases. Recently, he was involved in the discovery of novel fungal pathogens (Emmonsia species) causing invasive disease among HIV-infected persons in SA  Nelesh GovenderEdited

Ms Juliet Houghton  

Juliet Houghton is the Country Director for CHIVA South Africa, an NGO that works to build capacity and skills of health workers in South Africa to assist the government’s HIV response to children and adolescents. She is an HIV Nurse Specialist with experience in managing HIV-infected children and adolescents over the past 20 years. She is also a social anthropologist, having graduated with a distinction in the social anthropology of childhood and child development from Brunel University in London in 2005.   

 missing female

Mrs Lynsey Isherwood  
Ms Isherwood is the mHealth Programme Manager and Senior Medical Scientist for National Priority Programmes at the National Health Laboratory Service. In March 2014, Ms Isherwood was employed by the NPP to establish their mHealth Division; a task that has been successfully accomplished. Projects to date include miLINC and Treat-TB (two MDR-TB Linkage-to-Care mHealth solutions). In November 2015, miLINC was nominated within the top 5 finalists for the “Appsafrica Innovation Awards” from over 200 applicants across Africa. Ms Isherwood’s department is also involved in randomised controlled mHealth studies in HIV & TB and lastly, Ms Isherwood is responsible for the development of South Africa’s first ‘mHealth HUB’, a centralised mHealth business-intelligence HUB with the primary aim of interfacing, streamlining and centrally monitoring the country’s mHealth solutions through real-time dashboards and operational reporting  Lynsey IsherwoodEdited

Prof John Joska  

John Joska is an associate professor of psychiatry, head of the division of neuropsychiatry at Groote Schuur Hospital and director of the HIV mental health research unit, in the Department of Psychiatry and Mental Health at the University of Cape Town. He has established a research program in neuroHIV in the Western Cape Province, South Africa. The group has been funded by the NIMH, EDCTP, MRC and NRF. Projects include neurobiological investigations of the effects of HIV on brain structure and function, and neurobehavioral studies of adherence and psychological interventions. The group is interested in screening for neurocognitive disorders, as well as the combined effects of HIV and aging on the brain. 

 John JoskaEdited

Dr  Sumanth Karamchand  
Dr Karamchand is a 30-year-old male who graduated with a Bachelor of Pharmacy degree (Cum Laude) in 2006 and subsequently graduated Bachelor of Medicine, Bachelor of Surgery (Summa Cum Laude) in 2013. He is currently a medical-intern at Tygerberg Hospital and will take up a post as community service medical-officer at Khayelitsha Hospital in 2016. Sumanth is concurrently conducting his PhD research in Clinical Pharmacology. His research aims to investigate the relationship between antiretroviral therapy (ART) use and the incidence of metabolic disease (diabetes and osteoporosis) and cardio/cerebrovascular disease in the South African HIV-infected population. The study is important for the following reasons. (1) The relationship between ART  and metabolic complications, vascular disease (myocardial infarction and stroke) has not been studied in South African HIV-infected patients. (2) There is a rapid increase in the number HIV patients being placed on ART, which, in conjunction with an increasingly westernized lifestyle modifies the risk factors for cardiovascular and metabolic diseases in the HIV afflicted population, posing imminent risk for mortality other than that from opportunistic infection.  Sumanth KaramchandEdited

Prof Hester Klopper   
(PhD, MBA, FANSA, FAAN, ASSAf) Professional registration: RN; RM; RCHN; RPN; RNE; RNM  
Hester Klopper is an international academic and professional leader with extensive international networks in global health, public health, policy development, nursing and health care. She is the Chief Executive Officer of FUNDISA (Forum for University Nursing Deans in SA) and the Immediate Past President of Sigma Theta Tau International (2013-2015) (She is the first person outside of North America to be elected to the position of President of STTI). Prior to this position, she was the Dean of the Faculty of Community and Health Sciences, University of the Western Cape, South Africa, where she continues to hold a full professor appointment. In addition, she holds a professor position with INSINQ, a research focus area, based at North-West University (Potchefstroom Campus). She holds a Master’s degree (1992) and PhD (1994) from University of Johannesburg and a MBA (2002) from Luton University in the UK. As a scholar her research programme focuses on positive practice environments, patient safety and quality improvement. A continued interest is global health and the role nurses play in policy influence and strengthening health systems. She has been successful is securing funding for her work over the past decade of close to 50 million ZAR.  Hester KlopperEdited

Dr Rannokoe Lehloenya  

FCDerm (SA); MBChB (Medunsa)


Dr. Rannakoe Lehloenya graduated from the University of Cape Town with a Fellowship of the College of Dermatology of South Africa in 2009. His training started at the University of Lesotho where he obtained a BSc degree, majoring in Organic Chemistry and Biology, and went on to graduate with MBChB in MEDUNSA.

He has been practicing as a dermatologist, both in private practice and public service since 2009. Dr. Lehloenya is a Senior Lecturer at the University of Cape Town in the Department of Medicine. His research interest is in adverse drug reactions in the context of infectious diseases
 Rannakoe LehloenyaEdited

Ms Laura Lopez Gonzales  

Laura Lopez Gonzalez began covering HIV in 2003, when she completed an in-depth reporting project on HIV among men who have sex with men in Chicago and Cape Town as part of her undergraduate coursework at the Medill School of Journalism in Chicago. She later completed a master's thesis on counterintuitive links between conflict and HIV transmission in Mozambique as part of the University of Chicago’s Committee on International Relations before returning to South Africa.

She spent almost seven years as an HIV and health correspondent for the United Nations humanitarian news service, the Integrated Regional Information Networks (IRIN) covering southern Africa. In 2010, she was awarded a Gender and Media in Southern Africa Award for best sustained reporting for her work on forced sterilizations among HIV-positive women in Namibia and pregnancy-related HIV stigma. She has also written on HIV and health for the InterPress Service and aidsmap, the official scientific news provider of the International AIDS Conference. Her feature, “Will the world pay to end AIDS” was the organisation’s cover story for the 2012 AIDS Conference in Washington, DC.

She has also partnered with organizations such as the Johns Hopkins Center for Global Health and South Africa’s Aurum Institute to train fellow journalists in the reporting of clinical trials. Lopez joined Health-e in August 2013 as the news service’s print editor. Health-e News currently provides content for the Independent Newspapers, News24, the Daily Maverick as well as the SABC and eTV.

 Lopez GonzalezEdited

Dr Mluleki Marongo  

Mluleki Marongo is a human rights health activist and Legal Researcher working at a public interest law centre called SECTION27. SECTION27 is named after section 27 of the South African Constitution which state speaks about the right of access to health care services, the right to food, water, sanitation, social security and the right to not be refused emergency medical services.
His primary role is to assist and in some parts lead in advocating for access to health care services by health care users. He is involved in the following activities:
Strengthening of the Eastern Cape Health system with a specific focus on; curbing stock outs of essential medication such as medication for TB and ARVs; ensuring that emergency medical services and planned patient transport services are available and functional as well as facilitating that the necessary infrastructure, equipment, human resources and rehabilitation services exist at sufficient levels;
Mr Marongo is involved in strengthening, advocating, and securing justifiable working conditions for community health care workers and educating them about their rights. He also ensures medication for prisoners suffering from illnesses such as TB and HIV are distributed.

 blank male

Dr Carol Marshal  
MB ChB; DTM&H (London School of Tropical Medicine and Hygiene); MSc Mother and Child Health (University of London); MSc (Community Medicine) University of the Witwatersrand  
Dr Carol Marshall is the National Coordinator of District Clinical Specialist Teams responsible for clinical governance in relation to mothers and children at district level, and is a visiting lecturer for quality healthcare at the University of the Witwatersrand. She has worked extensively in Mozambique and South Africa as a paediatrician, a health service manager and an academic, and was the Africa Regional Director for the Micronutrient Initiative for a number of years. Since early 2008 she managed the Office of Standards Compliance in the National Department of Health and was responsible for guiding the development and monitoring the implementation of quality programmes in South Africa, including the development of the first national quality standards for health establishments, the set-up of a national Inspectorate and Complaints centre, and supporting the Parliamentary process that led to the promulgation of the National Health Amendment Act. From 2014 she was the interim CEO of the new public entity, the Office of Health Standards Compliance (OHSC) as it was being set up independently of the Department of Health as a regulator of healthcare quality, and led the drafting for public comment of the norms and standards and the procedural regulations to govern and empower the work of the Office  Carol MarshallEdited

Dr Thubelihle Mathole  

Thubelihle Mathole is a senior researcher at the School of Public Health at the University of Western Cape in South Africa. She holds a PhD in International health/Public Health from the University of Uppsala, Sweden.  She has worked in different areas such as Programme management, development of primary health care, health system strengthening, teaching and supervising students among others. She has been involved in a number of operational research projects in different countries in Sub Saharan Africa. Her areas of interest are health systems, global health, health economics, HIV/AIDS, maternal and child health,

 missing female

Dr Thabo Matsaseng  
MB ChB; F.C.O.G. (SA); CMSA  

Dr Thabo Matsaseng is the Head of Reproductive Medicine Unit at Stellenbosch University and Tygerberg Academic Hospital. Dr Matsaseng is a registered Reproductive medicine specialist. He recently submitted his PhD thesis on Cost Effective IVF strategies in assisted reproductive technologies (ART) since affordable IVF is his passion that he hopes one day will promote equal access to reproductive health.

 Thabo MatsasengEdited

Dr Jade Mogambery  

Dr Mogambery Graduated MBChB in 2005 from University of KwaZulu Natal. She commenced training in internal medicine in 2009 and then completed infectious disease sub-specialty training in 2015 in Grey’s Hospital Infectious Disease Unit.
Dr Mogambery is currently working as a consultant in internal medicine and Infectious diseases in Grey’s Hospital and is involved in outreach work within the HIV clinics in the Umgungundlovu district.
Jade holds a CAPRISA/ACC grant with the aim to strengthen referral systems and improve the management of complex HIV clinical cases in KZN.  She involved in a number of research projects and clinical trials as well as teaches undergraduate and postgraduates training in internal medicine.

 Jade MogamberyeDITED

Dr Michelle Moorhouse  



Michelle Moorhouse graduated from Wits University in South Africa. In 1999 she became involved in the management of HIV-positive patients, and co-founded the first HIV clinical trial centers in Port Elizabeth. Michelle established an HIV journal club in PE, which became the local chapter of the Southern African HIV Clinicians Society (SAHIVCS). In 2003 Michelle was awarded an Honorary Clinical Fellowship at the Royal Free Hospital in London. She also worked in the pharmaceutical industry, holding several senior HIV/virology posts in several large companies, which earned Michelle the respect of many leading international HIV clinicians.

Michelle returned to South Africa in 2007, re-establishing her general/HIV practice and setting up a research centre focusing on HIV clinical trials. Michelle consulted at an HIV clinic for an Eastern Cape based NPO, which signalled a change in her career. This branch of public health brought her closer to the other realities of the HIV/AIDS epidemic, providing an opportunity to play a greater part in tackling the disease that she has dedicated her career to so passionately.

 Michelle MoorhouseEdited

 Prof Mark Nicol  

MBBCh; DTM&H; MMed; FCPath; PhD


Prof Nicol is the Wernher and Beit Professor of Medical Microbiology at the University of Cape Town (UCT) and the National Health Laboratory Service (NHLS) of South Africa. His joint appointment with UCT and NHLS, which provides diagnostic microbiology services to public sector health facilities in South Africa, positions him well to engage in and support research at the clinical/diagnostic microbiology interface. His research interests are in the evaluation and implementation of novel diagnostic tests for tuberculosis, the cascade of care for patients with drug-resistant tuberculosis, the pathogenesis and etiology of pneumonia in infants and in the human microbiome.

 Mark NicolEdited

Dr Adam  Nosworthy  

MB BCh (Wits) FCP (SA) Certificate in Medical Oncology (SA) Specialist Physician / Medical Oncologist


Dr Adam Nosworthy is a Specialist Physician and Medical Oncologist in private practice at the Wits University Donald Gordon Medical Centre. Dr Nosworthy spent all of his training at Wits, he graduated with his MB BCh is 1996 doing his internship at this hospital and a year of medical officer time in the Department of Internal Medicine. He commenced his registrar training in 1999 and was awarded his Fellowship of the College of Medicine (Physicians) in 2002. During his training as a physician he represented the department registrars for two years on the Medicines Advisory Committee of the hospital and was awarded the Jock Gear Award for the Registrar offering most to his colleagues. He went on to sub-specialise in Medical Oncology being awarded the Certificate of Medical Oncology in 2004. Since this time he worked in the Division of Medical Oncology as a specialist and senior specialist. He resigned in 2011 and has been in private practice. Dr Nosworthy has been a board member of the South African Oncology Consortium since 2009 and currently an executive member of the South African Society of Medical Oncology – having organised the National Oncology Conference in 2011 at Sun City. He currently chairs a non-profit cancer organisation aimed at providing quality cancer care to all members of society – The Innovative Cancer Care Foundation. His oncology interests are vast but has a specific interest in GIT pathology, lung malignancies as well as haematological malignancies. His passion is HIV associated malignancies due to the stigma associated with these conditions.

 Adam Nosworthy

Dr  James Nuttall  

Dr Nuttall specialises in Paediatrician and Paediatric Infectious Diseases. He is a senior specialist and senior lecturer at Red Cross War Memorial Children’s Hospital and the School of Child and Adolescent Health, University of Cape Town

Dr Nuttall’s current areas of interest include, infants, children and adolescents with HIV infection and HIV/TB co-infection including early infant diagnosis, performance of HIV rapid tests in young children, ARV & TB drug dosing and pharmacokinetics, treatment failure and drug resistance.

Antimicrobial stewardship, antimicrobial treatment guidelines for children, development and implementation of antibiotic prescription chart for children, antimicrobial stewardship ward rounds and training.
 James Nuttall

Dr Tolullah Oni  

Dr Oni has a keen interest in urban health and population health transition; including the epidemiology of the interaction between HIV/TB and emerging non-communicable diseases. Having gained experience in the conduct of epidemiological studies from conception, initiation, and analysis to write up, dissemination and conclusion, I am conducting research into the interaction between HIV, TB, and emerging non communicable disease epidemics in high-burden settings and have raised grant funding to facilitate this goal. She is particularly interested in the spatio-temporal epidemiology of population health and the interaction with the environment.

Dr Oni is leading the establishment of an urban health research programme within the School of Public Health at the University of Cape Town. As a passionate advocate of health equity and health in all policies, she aims to continue to work as a Public Health Physician and Urban Epidemiologist at the interface of inter-disciplinary research, that provides evidence to support implementation of healthy public policies, and translation of research findings into policy and practice through collaboration with researchers and practitioners across disciplines and sectors
 Tolu OniEdited

Dr Kevin Rebe  
MBChB, FCP(SA), DTM&H, Dip HIV Man (SA)  

Kevin Rebe is an Infectious Diseases physician working for Health4men in Cape Town, a project of the Anova Health Institute.  Anova Health Institute is an independent non-profit health research and technical assistance program which partners with the South African Department of Health.  Dr Rebe obtained his graduate medical degree at the University of Cape Town and then specialised in Internal Medicine and sub-specialised in Infectious Diseases.  He has obtained diplomas in Tropical Medicine and Hygiene and HIV Management. 

Dr Rebe is an honorary senior lecturer in the Department of Medicine, University of Cape Town.  Dr Rebe has a particular interest in sexual health and wellbeing, especially among populations of men who have sex with men.  Aside from his clinical role, Dr Rebe undertakes MSM-related research particularly in the fields of HIV prevention in key populations and has published widely on diverse aspects of HIV.  Dr Rebe is a principle investigator at the Elton John Aids Foundation PrEP Demonstration Project currently running in the Western Cape and Gauteng.  He is also an investigator on a current BMS funded protocol investigating viral hepatitis C in South Africa.

Kevin Rebe

Dr Elna Rudolph  

Dr Elna Rudolph is a medical doctor working exclusively in the field of sexual medicine.  She is the clinical head of My Sexual Health – a multidisciplinary team of Sexual Health Professionals in Pretoria, Johannesburg, Cape Town and Witbank.  She is a part-time lecturer at the University of Pretoria, where she did her medical training.  She has a Higher Diploma in Sexual Health and HIV Medicine through the Colleges of Medicine in South Africa obtained a Master’s Degree in Sexual Health through the University of Sydney, Australia.  She is a Fellow of the European Committee for Sexual Medicine, an Honorary Fellow of the Council of Sex Education and Parenthood (International) as well as an Executive Board member of the South African Sexual Health Association (SASHA) and a member of the Advisory Committee for the World Association for Sexual Health (WAS).

 Elna RudolphEDITED

 Carmen Samb  

Carmen Samb is a Professional Nurse with 22 years experience. She has been in various management positions in South Africa and Saudi Arabia since 2000. Carmen hails from Cape Town where she completed her Nursing Degree at the University of the Western Cape and her Management Post Graduate Diploma at the University of Stellenbosch in 2007. Carmen’s passion is ensuring Quality Patient Care. She has contributed to quality patient care through her involvement in Quality Standards Implementation that covers accreditations such as COHSASA, ISO 9001:2007 as well as the Core Standards compliance at Netcare. She currently holds a Nursing Services Manager position of 4 hospitals in the Krugersdorp area for Netcare.

 Carmen SambeDITED

Ms Maria Sibanyoni  

Maria Sibanyoni is currently the Programme Manager for Sex Workers and Truckers project at Wits Reproductive Health and HIV Institute providing strategic development, oversight, stakeholder management and general management of the sex workers innovations and related truckers health, trucker stop communities and foreign sex work programmes.

She holds a Master of Public Health degree from the University of Witwatersrand, with expertise in programme implementation and quality improvement.

She has been working tirelessly as a patients advocate to improve the quality of health services and to ensure that health rights for sex workers are upheld all levels.
 Maria SibanyoniEdited

Dr Dennis Sifris  

Dennis Sifris is acknowledged as a pioneer in the HIV field in South Africa, and has specialised in HIV management since the start of the epidemic over 30 years ago.
As far back as 1985, he started the very first HIV Clinic in South Africa at the Johannesburg Hospital, and was the head of the clinic for five years. 
He is a co-founder of the Southern African HIV Clinicians Society, and was recently awarded Honorary Life Membership of the Society.
At present he is Chief Medical Officer for LifeSense Disease Management, overseeing the management of over 12,000 HIV patients.
He also currently serves as the managing editor of HIV/AIDS for the New York based

 Dennis SifriseDited

Prof Sibusiso Sifunda  
PhD, MPH  

Professor Sifunda is a Chief Research Specialist in the HIV/AIDS, STIs and TB (HAST) research programme of the Human Science Research Council, Pretoria. He also holds an appointment as an Honorary Professor at Walter Sisulu University. Prior to joining the HSRC Professor Sifunda was a Chief Specialist Scientist at the Medical Research Council of South Africa (MRC). He obtained his MPH in Epidemiology and Biostatics, from the University of Cape Town in 2002 and later completed a PhD in Public Health from the Universiteit Maastricht, the Netherlands in 2005. He has worked as a public health researcher since 1999 and has worked in various projects in HIV/AIDS, STIs, TB, Epidemiology, Health Promotion and Behavioral Sciences including large scale surveys such as the YRBS and community based interventions. Dr Sifunda has also worked as public health consultant and advisor in Botswana on a programme funded by the Gates Foundation. He was also a Co-PI in the Swaziland HIV/TB Prison Project (2010-2012) in a collaboration with Morehouse School of Medicine and the University of Swaziland He was also involved in a research capacity development Programme for tertiary institutions in Mozambique funded by the EU in partnership with MUNDO a Netherlands based development agency. He also serves as a scientific reviewer in several international public health journals such as Aids and Behavior, Health Education Research and the International Journal of Prisoner Health

 Sibusiso SifundaEdited

Dr Mark Sonderup  
Mark Sonderup was born and schooled in the Eastern Cape. He obtained a B Pharm degree from the University of Port Elizabeth in 1990 and an MBChB from the University of Cape Town in 1995. His internship training was in Port Elizabeth at Livingstone Hospital and his postgraduate training was at UCT and Groote Schuur Hospital where he obtained a FCP (SA) in 2002. He completed a 2 year fellowship in Hepatology in 2004 at the UCT/MRC Liver Research Centre and Liver Clinic at Groote Schuur Hospital in 2004. Currently he is a Senior Specialist in the Department of Medicine and Division of Hepatology at UCT and Groote Schuur Hospital. He is the Vice-Chairman of the South African Medical Association since 2009. His research interests include viral hepatitis, HIV/AIDS associated liver disease and porphyria.  Mark SonderupEdited

Dr Dave Spencer  
Dr David Spencer is a South African Infectious Diseases physician who has been active in caring for HIV-infected patients since the mid-1980s. After completing his ID training in the USA Dr Spencer assumed the role of head of the ID Clinic at the Johannesburg General Hospital (Charlotte Maxeke Johannesburg Academic Hospital) in 1991. He moved to private practice in 1997 and returned to academic medicine at the Helen Joseph Hospital in 2013. Over this period Dr Spencer has authored many scientific papers dealing with HIV medicine, authored the book “The Practice of HIV Medicine” in 2005 and was a founding member of the Southern African HIV Clinicians’ Society. Dr Spencer retired from Helen Joseph Hospital/University of the Witwatersrand at the end of 2015  David SpencerEdited

Ms Sasha Stevenson  



Sasha Stevenson is an qualified attorney at SECTION27. She works primarily on the right of access to heath care services and on the right to food and basic nutrition. 

Sasha's work takes her between government department boardrooms and remote villages in the Eastern Cape, the North West, Limpopo and Mpumalanga. SECTION27’s use of the law to catalyse social change means that, far from maintaining a traditional legal practice, Sasha is just as likely to be found speaking about rights to nurses and patients in a remote rural clinic as doing policy research or drafting court papers.

Prior to joining SECTION27, Sasha worked at the International Criminal Court in The Hague, before going on to complete an LLM in International Human Rights Law at the University of Cambridge. In 2009 she worked as a clerk for the late former Chief Justice Pius Langa.

 Sasha StevensonEdited

Dr  Henry Sunpath  

Dr. Sunpath is the chair of the organizing committee and one of the scientific advisors of AWACC 2015. He is a specialist family physician who has a wide range of research publications in the public health management of HIV, ART resistance and Tb co infection. He is an honorary senior lecturer at the NR Mandela School of medicine in the Infectious disease unit and a clinical fellow in the family medicine department. After working in the public health sector for the last 25 years, including about 15 years treating PLWHA at McCord hospital in Durban, he now holds a position in the Ethekwini DOH as district clinical specialist. His current work focuses on NHI reengineering projects in the Ethekwini health district, including the integrated clinical systems management programme. He is chair of the district task team for the MDRTB programme and quality improvement in the HAST services. His Current research project as co investigator is the NHI funded KZN ART drug resistance surveillance study.

 Henry SunpathEdited

Dr  Karl Technau  

Dr Technau work is focused around merging service delivery in the field of pediatric HIV and Prevention of Mother to Child Transmission of HIV with operational research. During the period of high maternal HIV prevalence in Southern Africa this is especially relevant as HIV has led to the reversal of the gains made in reducing infant, child and maternal mortality over the last decades.
As the principal investigator at Rahima Moosa Mother and Child Hospital, Dr Technau assists in contributing to the International epidemiological Databases for the Evaluation of AIDS (IeDEA-Southern African region) contribution to the International epidemiological Databases for the Evaluation of AIDS (IeDEA-Southern African region). Apart from contributing data and participating in IeDEA projects he has led a project on understanding the virological outcomes in children as well as coordinated the “Finding Infants with HIV Disease: Evaluation of Resistance, PMTCT Failures and Linking Access to Care (The FInHDER Study).
He has developed and introduced data systems that enable the HIV clinical services to report their activities. These data systems have been engaged in his operational research which has involved introducing peripartum HIV testing for new mothers in the Maternity Ward and involved work on improving follow-up of HIV positive mothers and their exposed infants through the use of cell phone technology.

Dr Technau is currently supervising Masters Students in the Department of Pediatrics and is currently enrolled at the University of the Witwatersrand PhD programme whilst conducting a study on point of care infant HIV diagnostics
 Karl Technau

Prof Rita Thom  
Rita Thom is a general psychiatrist with diverse interests and work experience in both the public and private sectors. She is currently the chairperson of the Southern Gauteng subgroup of the South African Society of Psychiatrists. She serves on the Human Research Ethics Committee at the University of the Witwatersrand and is an honorary Adjunct Professor in the Division of Psychiatry where she is involved in post-graduate teaching and research. She has been involved in developing training materials for clinicians to improve mental health care for people living with HIV (children, adolescents and adults). She has an interest and involvement in policy and service development, and plays an active role in training health care practitioners at all levels within the health system. She believes that there is a critical need for strong advocacy in accessing resources for people with mental disorders  Rita ThomEdited

Dr Cloete van Vuuren  
MB ChB, MFam Med, MMed (Int), Infectious Diseases Specialist  

Dr van Vuuren is currently the Head of Department of Medicine at 3 Military Hospital in Bloemfontein. Cloete is also an Associate Lecturer in the Division of Infectious Diseases, Department of Medicine at the University of the Free State.
Dr van Vuuren main interests include HIV Resistance, Tuberculosis and HIV, antibiotic stewardship, cost effective medicine as well as disease prevention

 Cloete van VuurenEdited

Dr Gert van Zyl  

Associate Professor, Division of Medical Virology, Stellenbosch University and Specialist Pathologist Tygerberg NHLS

Gert van Zyl is an associate professor Division of Medical Virology, Department Pathology, Stellenbosch University and NHLS Tygerberg Business Unit, Cape Town.  His research focuses on HIV therapy monitoring, HIV drug resistance and viral persistence on long term therapy, as relevant to resource limited settings and in particular the Southern African setting.

 Gert van ZylEdited

Dr  Michelle Wong  
Prof Michelle Wong is a graduate of the University of the Witwatersrand.  She trained as a general physician and subsequently as a Pulmonologist at Chris Hani Baragwanath Academic Hospital, and has been Head of the Division of Pulmonology since 1997  Michelle WongEdited

Ms Nataly Woollett  

M.A. (PhD candidate) LMHC, LCAT, RPT-S, ATR

Nataly Woollett – M.A. is currently the psychosocial technical team head at Wits Reproductive Health and HIV Institute (WRHI).  The focus of the team is to integrate psychosocial aspects of health and HIV into public health systems.  Nataly is also principal investigator on a randomized control trial delivery a nurse led intervention in antenatal clinics for pregnant women experiencing intimate partner violence.  Nataly has particular expertise in areas of mental health and HIV, gender based violence (GBV) and HIV, trauma and traumatic bereavement and the special needs of OVC and child/adolescent witnesses of violence.  She is a cofounder of an organization called Lawyers Against Abuse (LvA) that seeks to provide integrated legal services to victims of GBV.  Nataly has trained in the fields of psychology, art therapy and play therapy.  She is currently completing her PhD at Wits University on the mental health outcomes of HIV positive adolescents  Nataly WoollettEdited

Confirmed Sponsors

Confirmed Sponsors:

aspennew gilead logo mylan logo Janssen
Platinum Sponsor Emerald Sponsor Sapphire Sponsor  Gold Sponsor  Ruby Sponsor
(Registration, Nambadge and Lanyard) (Conference Supporter) (Book of Abstracts) (Welcome Function)  

 Adcock Logo2  Gems Metropolitan Health  SANOFI PasteurEdited abbvie logo 1 
Silver Sponsor
Copper Sponsor (USB) Nickel Sponsor Sponsor Speaker Grant Sponsor Workshop / Symposia
 (Gala Dinner)        

 gsk logo 1 Cipla Medpro Logo specpharm logo hetero logo Discovery Health
Sponsor Satellite Symposium Sponsor Unconditional Grant Sponsor Local Guest Speaker Sponsor General Sponsor Best Paper and Best Poster Prizes






Go to top